Fidaxomicin: first-in-class macrocyclic antibiotic

Fidaxomicin versus Vancomycin forClostridium difficileInfection

(2011) Thomas J. Louie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Inoculum, pH, and Cations on the In Vitro Activity of Fidaxomicin (OPT-80, PAR-101) against Clostridium difficile

(2010) F. Babakhani et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clostridium difficile: (Re)emergence of Zoonotic Potential

(2010) Maja Rupnik   CLINICAL INFECTIOUS DISEASES

Clostridium difficilein Food and Domestic Animals: A New Foodborne Pathogen?

(2010) L. Hannah Gould et al.   CLINICAL INFECTIOUS DISEASES

Global Epidemiology of Clostridium difficile Infection in 2010

(2010) Dale N. Gerding   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

(2010) Stuart H. Cohen et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Thirty-day mortality of Clostridium difficile infection in a UK National Health Service Foundation Trust between 2002 and 2008

(2010) A.P. McGowan et al.   JOURNAL OF HOSPITAL INFECTION

A review of mortality due to Clostridium difficile infection

(2010) J.A. Karas et al.   JOURNAL OF INFECTION

A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin

(2010) G. W. Tannock et al.   MICROBIOLOGY-SGM

Historical and changing epidemiology of healthcare-associated infections

(2009) A. Pearson   JOURNAL OF HOSPITAL INFECTION

Clostridium difficile–associated diarrhea: an emerging threat to pregnant women

(2008) Nadine G. Rouphael et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Safety, Tolerance, and Pharmacokinetic Studies of OPT-80 in Healthy Volunteers following Single and Multiple Oral Doses

(2008) Y. K. Shue et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Outcomes, Safety, and Pharmacokinetics of OPT-80 in a Phase 2 Trial with Patients with Clostridium difficile Infection

(2008) T. Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C. difficile Infection

(2008) T. J. Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

OPT-80, a macrocyclic antimicrobial agent for the treatment ofClostridium difficileinfections: a review

(2008) Michael Gerber et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Review of Current Literature on the Economic Burden of Clostridium difficile Infection

(2008) Erik R. Dubberke et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Actualités sur les infections à Clostridium difficile

(2007) K. Blanckaert et al.   REVUE DE MEDECINE INTERNE